GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Price-to-Tangible-Book

Moogene Medi Co (XKRX:322970) Price-to-Tangible-Book : (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Price-to-Tangible-Book?

As of today (2024-12-15), Moogene Medi Co's share price is ₩2390.00. Moogene Medi Co's Tangible Book per Share of . 20 for the quarter that ended in . 20 was ₩0.00. Hence, Moogene Medi Co's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Moogene Medi Co's Price-to-Tangible-Book or its related term are showing as below:

XKRX:322970's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Moogene Medi Co's share price is ₩2390.00. Moogene Medi Co's Book Value per Sharefor the quarter that ended in . 20 was ₩0.00. Hence, Moogene Medi Co's P/B Ratio of today is .


Moogene Medi Co Price-to-Tangible-Book Historical Data

The historical data trend for Moogene Medi Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Price-to-Tangible-Book Chart

Moogene Medi Co Annual Data
Trend
Price-to-Tangible-Book

Moogene Medi Co Semi-Annual Data
Price-to-Tangible-Book

Competitive Comparison of Moogene Medi Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Moogene Medi Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moogene Medi Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moogene Medi Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Moogene Medi Co's Price-to-Tangible-Book falls into.



Moogene Medi Co Price-to-Tangible-Book Calculation

Moogene Medi Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: . 20 )
=2390.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Moogene Medi Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Moogene Medi Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines